Enhanced Anti-Cancer Effects of Conditioned Medium from Hypoxic Human Adult Dermal Fibroblasts on Cervical Cancer Cells
Open Access
- 4 May 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (9) , 5134
Abstract
Hypoxia regulates fibroblast function by changing intracellular signaling and secretion factors, that influence the states of nearby cells. In this work, we investigated how medium (CM) from human adult dermal fibroblasts (HDFs) cultured in normoxic and hypoxic conditions affected cervical cancer (HeLa) cells. The HeLa cells showed decreased cell viability, increased apoptosis, and cell cycle arrest in response to CM from hypoxic-cultured HDFs (H-CM) compared with CM from normoxic-cultured HDFs (N-CM). Among the proteins up-regulated (>2-fold) in H-CM compared with N-CM, lymphotoxin-beta receptor (LTBR) decreased the viability of HeLa cells. Among the intracellular proteins down-regulated (>2-fold) in HeLa cells treated with H-CM compared with N-CM, the most enriched biological process GO term and KEGG pathway were protein deubiquitination and hsa05166:HTLV-I infection, respectively. In the protein–protein interaction network of intracellular proteins with altered expression (>2-fold), 1 up-regulated (TNF) and 8 down-regulated (ESR1, MCL1, TBP, CD19, LCK, PCNA, CHEK1, and POLA1) hub proteins were defined. Among the down-regulated hub proteins, the most enriched biological process GO term and KEGG pathway were leading strand elongation and hsa05166:HTLV-I infection, respectively. This study reveals that H-CM had stronger anti-cancer effects on cervical cancer cells than N-CM and induced intracellular signaling patterns related to those enhanced anti-cancer effects.Keywords
All Related Versions
Funding Information
- National Research Foundation of Korea (NRF) (2018M3A9E2023255, NRF-2016R1A6A3A11935666)
- Ministry of Science and ICT (2018M3A9E2023255, NRF-2016R1A6A3A11935666)
- Basic Science Research Program (2018M3A9E2023255, NRF-2016R1A6A3A11935666)
- Ministry of Education (2018M3A9E2023255, NRF-2016R1A6A3A11935666)
This publication has 55 references indexed in Scilit:
- The tumor suppressor function of LECT2 in human hepatocellular carcinoma makes it a potential therapeutic targetCancer Gene Therapy, 2011
- LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growthOncogene, 2011
- Cancer stem cells at the crossroads of current cancer therapy failures—Radiation oncology perspectiveSeminars in Cancer Biology, 2010
- Hypoxia regulates human lung fibroblast proliferation via p53-dependent and -independent pathwaysRespiratory Research, 2009
- Tumor necrosis factor and cancer, buddies or foes?Acta Pharmacologica Sinica, 2008
- Tumor–stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c‐Met pathwayInternational Journal of Cancer, 2006
- Targeting the Lymphotoxin-β Receptor with Agonist Antibodies as a Potential Cancer TherapyCancer Research, 2006
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- The Cytoplasmic Domain of the Lymphotoxin-β Receptor Mediates Cell Death in HeLa CellsJournal of Biological Chemistry, 1999
- The Lymphotoxin β Receptor Controls Organogenesis and Affinity Maturation in Peripheral Lymphoid TissuesImmunity, 1998